Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia

Table 3 Influence of CDKN2 deletion on complete molecular response (CMR)

	Patients (dele/wild)	CDKN2 deletion	Non CDKN2 deletion	P value
After induction^a	39/85	6 (15.4 %)	28 (32.9 %)	0.042
Pre-Allo-HSCT^a	34/62	18 (52.9 %)	48 (77.4 %)	0.013
Post-Allo-HSCT	31/58	27 (87 %)	54 (93.1 %)	0.442

ISSN: 1756-8722